Shockwave Medical Stock Price, News & Analysis (NASDAQ:SWAV) $172.52 -0.01 (-0.01%) (As of 12:40 PM ET) Add Compare Share Share Today's Range$169.45▼$172.9950-Day Range$160.99▼$215.6952-Week Range$157.00▼$315.95Volume133,688 shsAverage Volume574,057 shsMarket Capitalization$6.37 billionP/E Ratio26.87Dividend YieldN/APrice Target$263.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Shockwave Medical MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.80 Rating ScoreUpside/Downside52.5% Upside$263.00 Price TargetShort InterestHealthy4.36% of Shares Sold ShortDividend StrengthN/ASustainability-0.55Upright™ Environmental ScoreNews Sentiment0.35Based on 6 Articles This WeekInsider TradingSelling Shares$9.07 M Sold Last QuarterProj. Earnings Growth24.86%From $3.62 to $4.52 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.3.24 out of 5 starsMedical Sector9th out of 958 stocksSurgical & Medical Instruments Industry4th out of 77 stocks 4.4 Analyst's Opinion Consensus RatingShockwave Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 8 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $263.00, Shockwave Medical has a forecasted upside of 52.5% from its current price of $172.49.Amount of Analyst CoverageShockwave Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.36% of the outstanding shares of Shockwave Medical have been sold short.Short Interest Ratio / Days to CoverShockwave Medical has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Shockwave Medical has recently decreased by 0.62%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldShockwave Medical does not currently pay a dividend.Dividend GrowthShockwave Medical does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreShockwave Medical has received a 72.86% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Diagnostic and treatment machines" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Shockwave Medical is -0.55. Previous Next 1.9 News and Social Media Coverage News SentimentShockwave Medical has a news sentiment score of 0.35. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Shockwave Medical this week, compared to 6 articles on an average week.Search InterestOnly 19 people have searched for SWAV on MarketBeat in the last 30 days. This is a decrease of -5% compared to the previous 30 days.MarketBeat Follows10 people have added Shockwave Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Shockwave Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,066,440.00 in company stock.Percentage Held by InsidersOnly 3.40% of the stock of Shockwave Medical is held by insiders.Percentage Held by Institutions87.35% of the stock of Shockwave Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Shockwave Medical are expected to grow by 24.86% in the coming year, from $3.62 to $4.52 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Shockwave Medical is 26.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 120.28.Price to Earnings Ratio vs. SectorThe P/E ratio of Shockwave Medical is 26.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 130.76.Price to Earnings Growth RatioShockwave Medical has a PEG Ratio of 9.79. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioShockwave Medical has a P/B Ratio of 12.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Shockwave Medical Stock (NASDAQ:SWAV)ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters for use in our IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter for use in IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Read More SWAV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SWAV Stock News HeadlinesDecember 6, 2023 | finance.yahoo.comShockwave Medical (SWAV) Down 1% Since Last Earnings Report: Can It Rebound?December 5, 2023 | americanbankingnews.comShockwave Medical (NASDAQ:SWAV) Price Target Cut to $223.00 by Analysts at Morgan StanleyDecember 7, 2023 | Edge On The Street (Ad)An Unusual Way to Invest in GoldMost financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines. December 1, 2023 | finance.yahoo.comShockwave Medical (SWAV) Fell on Concerns Over the New GLP-1 Diabetes/Obesity DrugsNovember 30, 2023 | americanbankingnews.comIsaac Zacharias Sells 4,000 Shares of Shockwave Medical, Inc. (NASDAQ:SWAV) StockNovember 29, 2023 | finance.yahoo.comInsider Sell Alert: President, CCO Isaac Zacharias Offloads 4,000 Shares of ShockWave Medical ...November 29, 2023 | americanbankingnews.comShockwave Medical, Inc. (NASDAQ:SWAV) Receives Average Recommendation of "Moderate Buy" from AnalystsNovember 27, 2023 | americanbankingnews.comShockwave Medical (NASDAQ:SWAV) vs. Nyxoah (NASDAQ:NYXH) Financial SurveyDecember 7, 2023 | Edge On The Street (Ad)An Unusual Way to Invest in GoldMost financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines. November 23, 2023 | morningstar.comShockWave Medical Inc SWAVNovember 22, 2023 | finance.yahoo.comInsider Sell Alert: Director Frank Watkins Sells 3,000 Shares of ShockWave Medical Inc (SWAV)November 18, 2023 | finance.yahoo.comInsider Sell Alert: President & CEO Douglas Godshall Sells 5,000 Shares of ShockWave ...November 15, 2023 | finance.yahoo.comShockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare ConferenceNovember 9, 2023 | finance.yahoo.comShould You Think About Buying Shockwave Medical, Inc. (NASDAQ:SWAV) Now?November 8, 2023 | seekingalpha.comShockwave Medical: Buying The DipNovember 7, 2023 | markets.businessinsider.comHeart Device Maker Shockwave Medical Is One Of The Best Assets In MedTech Category: AnalystNovember 7, 2023 | finance.yahoo.comA Bull Market Might Be Coming, but These 2 Stocks Aren't Along for the Ride Just YetNovember 7, 2023 | msn.comShockwave Medical (SWAV) Q3 Earnings Beat, Revenues Rise Y/YNovember 7, 2023 | finance.yahoo.comShockwave Medical (SWAV) Q3 2023 Earnings Call TranscriptNovember 7, 2023 | finance.yahoo.comShockWave Medical, Inc. (NASDAQ:SWAV) Q3 2023 Earnings Call TranscriptNovember 6, 2023 | finance.yahoo.comShockwave Medical Reports Third Quarter 2023 Financial ResultsNovember 3, 2023 | finance.yahoo.comShould You Buy ShockWave Medical (SWAV) Ahead of Earnings?November 2, 2023 | finance.yahoo.comShockwave Medical (SWAV) Crossed Above the 50-Day Moving Average: What That Means for InvestorsNovember 1, 2023 | finance.yahoo.comShockwave Medical (SWAV) Just Overtook the 20-Day Moving AverageOctober 30, 2023 | finance.yahoo.comShockwave Medical (SWAV) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOctober 26, 2023 | finance.yahoo.comWall Street Analysts See a 27.54% Upside in Shockwave Medical (SWAV): Can the Stock Really Move This High?October 26, 2023 | finance.yahoo.comDoes Shockwave Medical (NASDAQ:SWAV) Deserve A Spot On Your Watchlist?See More Headlines Receive SWAV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shockwave Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/06/2023Today12/07/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:SWAV CUSIPN/A CIK1642545 Webwww.shockwavemedical.com Phone(877) 775-4846FaxN/AEmployees1,001Year FoundedN/APrice Target and Rating Average Stock Price Target$263.00 High Stock Price Target$315.00 Low Stock Price Target$218.00 Potential Upside/Downside+52.4%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$6.42 Trailing P/E Ratio26.87 Forward P/E Ratio47.66 P/E Growth9.79Net Income$216 million Net Margins36.33% Pretax Margin24.35% Return on Equity42.41% Return on Assets26.44% Debt Debt-to-Equity Ratio1.22 Current Ratio14.43 Quick Ratio13.19 Sales & Book Value Annual Sales$671.28 million Price / Sales9.48 Cash Flow$5.80 per share Price / Cash Flow29.75 Book Value$14.15 per share Price / Book12.19Miscellaneous Outstanding Shares36,897,000Free Float35,643,000Market Cap$6.37 billion OptionableNot Optionable Beta0.87 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Douglas E. Godshall M.B.A. (Age 58)President, CEO & Director Comp: $1.57MMr. Daniel K. Puckett MBA (Age 59)CFO, Principal Financial Officer & Secretary Comp: $797.38kMr. Isaac Zacharias (Age 48)Chief Commercial Officer Comp: $908.02kMr. Daniel Hawkins (Age 56)Founder and Senior Advisor Mr. John M. Adams (Age 76)Co-Founder and Technical Advisor Mr. Luis MoralesSenior Vice President of Global OperationsMs. Trinh Phung (Age 45)Chief Accounting Officer, Principal Accounting Officer & VP of Finance Ms. Debbie KasterVice President of Investor RelationsMr. Hajime Tada J.D.General Counsel & SecretaryMr. Robert FletcherSenior Vice President of Marketing & Market AccessMore ExecutivesKey CompetitorsGlobus MedicalNYSE:GMEDStevanato GroupNYSE:STVNPenumbraNYSE:PENInspire Medical SystemsNYSE:INSPHaemoneticsNYSE:HAEView All CompetitorsInsiders & InstitutionsCitigroup Inc.Sold 29,780 shares on 12/6/2023Ownership: 0.010%Wellington Management Group LLPBought 453,048 shares on 12/1/2023Ownership: 4.894%American Century Companies Inc.Bought 89,094 shares on 11/30/2023Ownership: 0.463%Isaac ZachariasSold 4,000 sharesTotal: $694,320.00 ($173.58/share)Deutsche Bank AGSold 11,715 shares on 11/24/2023Ownership: 0.024%View All Insider TransactionsView All Institutional Transactions SWAV Stock Analysis - Frequently Asked Questions Should I buy or sell Shockwave Medical stock right now? 10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" SWAV shares. View SWAV analyst ratings or view top-rated stocks. What is Shockwave Medical's stock price target for 2024? 10 brokerages have issued 12-month price targets for Shockwave Medical's stock. Their SWAV share price targets range from $218.00 to $315.00. On average, they anticipate the company's share price to reach $263.00 in the next year. This suggests a possible upside of 52.5% from the stock's current price. View analysts price targets for SWAV or view top-rated stocks among Wall Street analysts. How have SWAV shares performed in 2023? Shockwave Medical's stock was trading at $205.61 at the beginning of the year. Since then, SWAV shares have decreased by 16.1% and is now trading at $172.49. View the best growth stocks for 2023 here. When is Shockwave Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, February 15th 2024. View our SWAV earnings forecast. How were Shockwave Medical's earnings last quarter? Shockwave Medical, Inc. (NASDAQ:SWAV) posted its quarterly earnings data on Monday, November, 6th. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.81 by $0.11. The firm earned $186.02 million during the quarter, compared to analysts' expectations of $184.71 million. Shockwave Medical had a net margin of 36.33% and a trailing twelve-month return on equity of 42.41%. The business's revenue for the quarter was up 41.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.92 EPS. What ETFs hold Shockwave Medical's stock? ETFs with the largest weight of Shockwave Medical (NASDAQ:SWAV) stock in their portfolio include Neuberger Berman Disrupters ETF (NBDS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Janus Henderson Small/Mid Cap Growth Alpha ETF (JSMD), First Trust Indxx Medical Devices ETF (MDEV), Invesco S&P MidCap 400 Pure Growth ETF (RFG), Alger Mid Cap 40 ETF (FRTY), WisdomTree U.S. Growth & Momentum Fund (WGRO) and First Trust Health Care AlphaDEX Fund (FXH). What is Doug Godshall's approval rating as Shockwave Medical's CEO? 8 employees have rated Shockwave Medical Chief Executive Officer Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among the company's employees. What other stocks do shareholders of Shockwave Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Block (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA). When did Shockwave Medical IPO? (SWAV) raised $75 million in an initial public offering on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers. Who are Shockwave Medical's major shareholders? Shockwave Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include FMR LLC (6.85%), Wellington Management Group LLP (4.89%), Artisan Partners Limited Partnership (3.80%), Invesco Ltd. (1.92%), Allspring Global Investments Holdings LLC (1.76%) and Morgan Stanley (1.17%). Insiders that own company stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Maria Sainz, Sara Toyloy and Trinh Phung. View institutional ownership trends. How do I buy shares of Shockwave Medical? Shares of SWAV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:SWAV) was last updated on 12/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shockwave Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.